1. Home
  2. CRM vs VRTX Comparison

CRM vs VRTX Comparison

Compare CRM & VRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CRM

Salesforce Inc.

N/A

Current Price

$191.92

Market Cap

148.0B

Sector

Technology

ML Signal

N/A

Logo Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated

N/A

Current Price

$514.89

Market Cap

123.4B

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
CRM
VRTX
Founded
1999
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
EDP Services
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
148.0B
123.4B
IPO Year
2003
2006

Fundamental Metrics

Financial Performance
Metric
CRM
VRTX
Price
$191.92
$514.89
Analyst Decision
Buy
Buy
Analyst Count
36
29
Target Price
$278.74
$539.69
AVG Volume (30 Days)
11.1M
1.3M
Earning Date
05-27-2026
05-04-2026
Dividend Yield
0.97%
N/A
EPS Growth
22.64
836.54
EPS
2.42
8.33
Revenue
$8,391,984,000.00
$2,488,652,000.00
Revenue This Year
$12.24
$10.79
Revenue Next Year
$9.47
$10.47
P/E Ratio
$81.51
$60.71
Revenue Growth
25.87
46.20
52 Week Low
$146.32
$374.17
52 Week High
$269.11
$546.17

Technical Indicators

Market Signals
Indicator
CRM
VRTX
Relative Strength Index (RSI) 55.88 60.00
Support Level $175.19 $458.05
Resistance Level $208.10 $539.92
Average True Range (ATR) 6.71 13.97
MACD 0.57 2.56
Stochastic Oscillator 52.82 60.41

Price Performance

Historical Comparison
CRM
VRTX

About CRM Salesforce Inc.

Salesforce provides enterprise cloud computing solutions. The company offers customer relationship management technology that brings companies and customers together. Its Customer 360 platform helps the group deliver a single source of truth, connecting customer data across systems, apps, and devices to help companies sell, service, market, and conduct commerce. It also offers Service Cloud for customer support, Marketing Cloud for digital marketing campaigns, Commerce Cloud as an e-commerce engine, the Salesforce Platform, which allows enterprises to build applications, and other solutions, such as MuleSoft for data integration.

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

Share on Social Networks: